BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9594444)

  • 1. Characterization of leukemic cells in CD2/CD19 double positive acute lymphoblastic leukemia.
    Manabe A; Mori T; Ebihara Y; Koyama T; Okuyama I; Hosoya R; Kaneko M; Ishimoto K; Nakahata T; Nakazawa S
    Int J Hematol; 1998 Jan; 67(1):45-52. PubMed ID: 9594444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues.
    Uckun FM; Muraguchi A; Ledbetter JA; Kishimoto T; O'Brien RT; Roloff JS; Gajl-Peczalska K; Provisor A; Koller B
    Blood; 1989 Mar; 73(4):1000-15. PubMed ID: 2784064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
    Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
    Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study.
    Uckun FM; Gaynon P; Sather H; Arthur D; Trigg M; Tubergen D; Nachman J; Steinherz P; Sensel MG; Reaman GR
    Blood; 1997 Apr; 89(7):2488-93. PubMed ID: 9116293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three cases.
    Ghodke K; Bibi A; Rabade N; Patkar N; Subramanian PG; Kadam PA; Badrinath Y; Ghogale S; Gujral S; Tembhare P
    Cytometry B Clin Cytom; 2017 Jul; 92(4):315-318. PubMed ID: 27018867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of lymphocyte surface markers in acute myeloid leukemia.
    Ball ED; Davis RB; Griffin JD; Mayer RJ; Davey FR; Arthur DC; Wurster-Hill D; Noll W; Elghetany MT; Allen SL
    Blood; 1991 May; 77(10):2242-50. PubMed ID: 1709379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The expression of CD19 in 210 cases of childhood acute leukemia and its significance].
    Chen YH; Tang YM; Shen HQ; Song H; Yang SL; Shi SW; Qian BQ; Xu WQ; Ning BT
    Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):188-91. PubMed ID: 15144712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression.
    Cantù-Rajnoldi A; Putti MC; Schirò R; Biondi A; Cattoretti G; Valeggio C; Castagni M; Basso G
    Haematologica; 1992; 77(5):384-91. PubMed ID: 1362385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD2 + CD19 + acute lymphoblastic leukaemia in 16 children and adults: clinical and biological features. Groupe d'Etude Immunologique des Leucémies (G.E.I.L.).
    Lenormand B; Vannier JP; Bene MC; Falkenrodt A; Bayle C; Favre M; Garand R; Griveau AM; Briquet MT; Reman O
    Br J Haematol; 1993 Apr; 83(4):580-8. PubMed ID: 7686033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases.
    Rozenova KA; Jevremovic D; Reichard KK; Nguyen P; Otteson GE; Timm MM; Horna P; Olteanu H; Shi M
    Hum Pathol; 2021 Aug; 114():66-73. PubMed ID: 34019867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
    Iwamoto S; Deguchi T; Ohta H; Kiyokawa N; Tsurusawa M; Yamada T; Takase K; Fujimoto J; Hanada R; Hori H; Horibe K; Komada Y
    Int J Hematol; 2011 Aug; 94(2):185-192. PubMed ID: 21800074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic challenges in diagnosis of CD79a negativity in a patient with B acute lymphoblastic leukemia harboring intrachromosomal amplification of chromosome 21: a case report.
    Berhili A; Bensalah M; ElMalki J; Elyagoubi A; Seddik R
    J Med Case Rep; 2021 Oct; 15(1):531. PubMed ID: 34706776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of human B cell precursor-leukemia cell lines.
    Matsuo Y; Drexler HG
    Leuk Res; 1998 Jul; 22(7):567-79. PubMed ID: 9680106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia.
    Astsaturov IA; Matutes E; Morilla R; Seon BK; Mason DY; Farahat N; Catovsky D
    Leukemia; 1996 May; 10(5):769-73. PubMed ID: 8656670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
    Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
    Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.